Evidence map›Paper›PMID 23792437›Full record

ArticleCornea2013

Dysregulated heme oxygenase-ferritin system in pterygium pathogenesis.

Timothy Fox, Katherine H Gotlinger, Michael W Dunn, Olivia L Lee, Tatyana Milman, Gerald Zaidman, Michal L Schwartzman, Lars Bellner

Abstract read
In one paragraph

Article in Cornea, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Peroxiredoxin I and II in human eyes: cellular distribution and association with pterygium and DNA damage.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2014
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Timothy FoxDepartment of Pharmacology, New York Medical College, Valhalla, NY, USA.
Katherine H Gotlinger
Michael W Dunn
Olivia L Lee
Tatyana Milman
Gerald Zaidman
Michal L Schwartzman
Lars Bellner
New York Medical College · USNew York Eye and Ear Infirmary · US

Funding

Vasoregulatory Function of CYP2E1-Derived EicosanoidsP01HL034300 · NHLBI · NEW YORK MEDICAL COLLEGE · PI JIANG, HOULI · 1985 to 2015
$33.4M
CORNEAL ARACHIDONATE METABOLITES VIA CYTOCHROME P450R01EY006513 · NEI · NEW YORK MEDICAL COLLEGE · PI SCHWARTZMAN, MICHAL LANIADO · 1987 to 2010
$4.2M
NEI NIH HHS EY06513NEI NIH HHS R01 EY006513NHLBI NIH HHS HL34300NHLBI NIH HHS P01 HL034300
6 · The paper itself

Abstract

purposeCyclooxygenase (COX)-, lipoxygenase (LOX)-, and cytochrome P450 monooxygenase (CYP)-derived eicosanoids have been implicated in ocular surface inflammation and neovascularization. These eicosanoids are subjected to regulation by enzymes, such as heme oxygenases (HOs) and ferritin.

methodsQuantitative polymerase chain reaction and lipidomics based on liquid chromatography-tandem mass spectrometry were performed on pterygia from patients undergoing surgical pterygium excision. Control tissues consisted of donor corneas. In addition, lipidomics based on liquid chromatography-tandem mass spectrometry was performed on tears collected from patients before the surgery.

resultsMessenger RNA (mRNA) expression of HO-2, the constitutive HO isoform, was upregulated by 40% in pterygia compared with control tissue, whereas the mRNA level of the inducible form, HO-1, was downregulated by more than 50%. Levels of CYP4B1 mRNA showed an approximate 2-fold increase in pterygia compared with control. Lipidomic analysis of tissues indicated a moderate elevation in Prostaglandin E2 and thromboxane B2 levels in pterygia compared with control. Among the LOX-derived metabolites, the antiinflammatory-hydroxyeicosatetraenoic acid (15-HETE) levels were significantly reduced in pterygia (79.3 ± 48.11 pg/mg protein) compared with control (586.2 ± 213.5 pg/mg protein), whereas the proinflammatory LOX- and CYP4B1-derived 12-HETE levels were 10-fold higher in pterygia (2768 ± 832.3 pg/mg protein) compared with control (231.4 ± 87.35 pg/mg protein). Prostaglandin E2 and HETEs were also present in tears from patients with pterygium but were not detected in tears from healthy volunteers. The mRNA expression levels of both light and heavy chain ferritin were 60% and 30% lower, respectively, in pterygia compared with control.

conclusionsWe believe that a dysfunctional HO-ferritin system leads to increased levels of proinflammatory mediators, thus contributing to the inflammation characteristic of pterygia.

Indexed as

12-Hydroxy-5,8,10,14-eicosatetraenoic AcidAdultAryl Hydrocarbon HydroxylasesChromatography, High Pressure LiquidDinoprostoneFemaleFerritinsGene Expression Regulation, EnzymologicHeme Oxygenase-1Heme Oxygenase (Decyclizing)HumansHydroxyeicosatetraenoic AcidsIsoenzymesMaleMiddle AgedPterygium12-Hydroxy-5,8,10,14-eicosatetraenoic Acid15-hydroxy-5,8,11,13-eicosatetraenoic acidAryl Hydrocarbon Hydroxylasescytochrome P-450 CYP4B1DinoprostoneFerritinsHeme Oxygenase-1heme oxygenase-2Heme Oxygenase (Decyclizing)HMOX1 protein, humanHydroxyeicosatetraenoic AcidsIsoenzymesRNA, MessengerThromboxane B2

Identifiers

PMID23792437
PMCPMC3740074
OpenAlexW1995831337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.